ASURAGEN INCORPORATED - QUANTIDEX QPCR BCR ABL IS KIT REAGENTS AND QUANTIDEX QPCR BCR-ABL MINOR KIT REAGENTS.

PIID: W81K0022P0237Solicitation ID: W81K0022Q0112

Signed Date: Nov 25, 2025Effective Date: Oct 1, 2022End Date: Closes in 110 days

Award $

$552K

Vendor

ASURAGEN INCORPORATED

NAICS

325413

Signed Date

Nov 25, 2025

Key Details

Dollars Obligated

$552,493

Base & All Options

Awarding Agency

Department of Defense

Awarding Sub-Agency

Department of the Army

NAICS Code

325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Product Service Code

6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES

Extent Competed

NOT COMPETED UNDER SAP

Number of Offers

Place of Performance

JBSA FT SAM HOUSTON, TX, 782344400, CD-TX-21

Description

QUANTIDEX QPCR BCR ABL IS KIT REAGENTS AND QUANTIDEX QPCR BCR-ABL MINOR KIT REAGENTS.

Context & Analysis

On Nov 25, 2025, Department of Defense obligated $552,493 to ASURAGEN INCORPORATED for quantidex qpcr bcr abl is kit reagents and quantidex qpcr bcr-abl minor kit reagents.. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in JBSA FT SAM HOUSTON, TX. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.